Stp1 and Stk1: The yin and yang of vancomycin sensitivity and virulence in vancomycin-intermediate staphylococcus aureus strains

Journal of Infectious Diseases

Volumn 205, Issue 11, 2012, Pages 1625-1627

  Cheung, Ambrose ^a   Duclos, Bertrand ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; PHOSPHATASE; PHOSPHATASE STP1; PROTEIN SERINE THREONINE KINASE; SERINE THREONINE PHOSPHATASE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; DOWN REGULATION; ENZYME STRUCTURE; GENE CONTROL; GENE DELETION; GENE MUTATION; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS AUREUS; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; VIRUS MUTATION;

ANIMALS; FEMALE; PHOSPHOPROTEIN PHOSPHATASES; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 84861038627     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis255     Document Type: Review

References (21)

1. Bakal CJ, Davies JE. No longer an exclusive club: eukaryotic signalling domains in bacteria. Trends Cell Biol 2000; 10:32-8. (Pubitemid 30017864)
2. Ohlsen K, Donat S. The impact of serine/threonine phosphorylation in Staphylococcus aureus. Int J Med Microbiol 2010; 300:137-41.
3. Molle V, Kremer L. Division and cell envelope regulation by Ser/Thr phosphorylation: Mycobacterium shows the way. Mol Microbiol 2010; 75:1064-77.
4. Av-Gay Y, Everett M. The eukaryotic-like Ser/Thr protein kinases of Mycobacterium tuberculosis. TrendsMicrobiol 2000; 8:238-44. (Pubitemid 30236245)
5. Beltramini AM, Mukhopadhyay CD, Pancholi V. Modulation of cell wall structure and antimicrobial susceptibility by a Staphylococcus aureus eukaryote-like serine/threonine kinase and phosphatase. Infect Immun 2009; 77:1406-16.
6. Debarbouille M, Dramsi S, Dussurget O, et al. Characterization of a serine/threonine kinase involved in virulence of Staphylococcus aureus. J Bacteriol 2009; 191:4070-81.
7. Tamber S, Schwartzman J, Cheung AL. Role of PknB kinase in antibiotic resistance and virulence in community-acquired methicillin-resistant Staphylococcus aureus strain USA300. Infect Immun 2010; 78:3637-46.
8. Cameron DR, Ward DV, Kostoulias X, et al. The serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in S. aureus. J Infect Dis 2011; 205:1677-87.
9. Mwangi MM, Wu SW, Zhou Y, et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci USA 2007; 104:9451-6. (Pubitemid 47185800)
10. Renzoni A, Andrey DO, Jousselin A, et al. Whole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in Staphylococcus aureus. PLoS One 2011; 6:e21577.
11. Yang SJ, Bayer AS, Mishra NN, et al. The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides. Infect Immun 2012; 80: 74-81.
12. Yin S, Daum RS, Boyle-Vavra S. VraSR two component regulatory system and its role in induction of pbp2 and vraSR expression by cell wall antimicrobials in Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50:336-43. (Pubitemid 43042941)
13. Kato Y, Suzuki T, Ida T, Maebashi K. Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR. J Antimicrob Chemother 2010; 65:37-45.
14. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol 2003; 49:807-21. (Pubitemid 36918698)
15. Gardete S, Kim C, Hartmann BM, et al. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant S. aureus strain of clonal type USA300. PLoS Pathog 2011; e1002505.
16. Shoji M, Cui L, Iizuka R, et al. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus. Antimicrob Agents Chemother 2011; 55:3870-81.
17. Szurmant H, Mohan MA, Imus PM, Hoch JA. YycH and YycI interact to regulate the essential YycFG two-component system in Bacillus subtilis. J Bacteriol 2007; 189:3280-9. (Pubitemid 46697418)
18. Cui L, Ma X, Sato K, et al. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 2003; 41:5-14. (Pubitemid 36098547)
19. Liebeke M, Meyer H, Donat S, Ohlsen K, Lalk M. A metabolomic view of Staphylococcus aureus and its ser/thr kinase and phosphatase deletion mutants: involvement in cell wall biosynthesis. Chem Biol 2010; 17:820-30.
20. Peleg AY, Monga D, Pillai S, Mylonakis E, Moellering RC Jr., Eliopoulos GM. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis 2009; 199:532-6.
21. Burnside K, Lembo A, de Los RM, et al. Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase. PLoS One 2010; 5:e11071.